- World rank, all time
- #37,603 of 42,892
- Rank in Norway
- #211 of 232
- Research works
- 129 ▼ 39% vs 2013–17
- Citations
- 2.5k 19.5 per fractional work
- Top-10% rate
- 27.8% record average 16.5%
- Open access
- 56% world 28%
What does Hospital of Southern Norway specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.9× the share of its output that it takes of world research.
- MedicineField · 20.8 works3.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
- Medicine 3.9×
- Immunology and Microbiology 3.2×
- Pharmacology, Toxicology and Pharmaceutics 2.2×
- Psychology 1.8×
- Health Professions 1.3×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Neuroscience 0.4×
- Decision Sciences 0.3×
- Economics, Econometrics and Finance 0.2×
- Computer Science 0.2×
- Social Sciences 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Environmental Science 0.0×
- Mathematics 0.0×
Who are the top researchers at Hospital of Southern Norway?
Ranked on the composite score, Glenn Haugeberg lead among researchers whose main affiliation is Hospital of Southern Norway.
- 1 Glenn Haugeberg Norway · #1,085,408 worldwide 16 citations · 31 works
Which keywords describe research at Hospital of Southern Norway?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Autoantibodies, Fibrosis, Treatment, Epidemiology, Endothelial Dysfunction, TGF-ß Signaling, Immunosuppressive Therapy and Pulmonary Involvement.
- Obesity
- Cardiovascular Disease
- Biological Therapy
- Myofibroblast
- Epithelial-Mesenchymal Transition
- Interstitial Lung Disease
- Quality of Life
- Pulmonary Involvement
- Immunosuppressive Therapy
- Endothelial Dysfunction
- Treatment
- Epidemiology
- Autoantibodies
- Fibrosis
- Inflammation
- TGF-ß Signaling
- Cardiovascular Risk
- Systemic Sclerosis
- Cytokines
- Risk Factors
- Idiopathic Pulmonary Fibrosis
- TGF-ß
- Rheumatoid Arthritis
- Complications
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Autoantibodies4▲ 55×5 topics
- Epidemiology3▲ 2.9×32 topics
- Fibrosis3▲ 60×4 topics
- Treatment3▲ 7.7×13 topics
- Inflammation2▲ 3.7×15 topics
- Endothelial Dysfunction2▲ 31×3 topics
- TGF-ß Signaling2▲ 105×2 topics
- Immunosuppressive Therapy2▲ 34×3 topics
- Cardiovascular Risk2▲ 20×5 topics
- Pulmonary Involvement2▲ 169×1 topic
- Systemic Sclerosis2▲ 169×1 topic
- Quality of Life2▲ 3.8×14 topics
- Cytokines1▲ 17×4 topics
- Interstitial Lung Disease1▲ 77×2 topics
- Risk Factors1▲ 4.4×10 topics
- Epithelial-Mesenchymal Transition1▲ 48×2 topics
- Idiopathic Pulmonary Fibrosis1▲ 96×1 topic
- Myofibroblast1▲ 96×1 topic
- TGF-ß1▲ 29×2 topics
- Biological Therapy1▲ 70×1 topic
- Rheumatoid Arthritis1▲ 41×1 topic
- Cardiovascular Disease1▲ 3.4×9 topics
- Complications1▲ 7.3×5 topics
- Obesity1▲ 5.0×7 topics
Which research topics does Hospital of Southern Norway publish most on?
By volume in 2022–2025: Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Rheumatoid Arthritis Research and Therapies and Spondyloarthritis Studies and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 2 works
- 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
- 3 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 4 Spondyloarthritis Studies and Treatments Rheumatology 1 works
- 5 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 6 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 0 works
- 7 Otitis Media and Relapsing Polychondritis Rheumatology 0 works
- 8 Acute Myocardial Infarction Research Cardiology and Cardiovascular Medicine 0 works
- 9 Substance Abuse Treatment and Outcomes Epidemiology 0 works
- 10 Vasculitis and related conditions Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hospital of Southern Norway's research output changed?
Output in 2018–2022 was 39% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Arendal
- Sørlandet Hospital Arendal
- Grid-Arendal
- Avinet (Norway)
- Provista (Norway)
- Norsafe (Norway)
- Csub (Norway)
- Macgregor Pusnes (Norway)
- Norsk Kirkegårdsservice (Norway)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.